Market Trends of United States Heparin Industry
This section covers the major market trends shaping the US Heparin Market according to our research experts:
Deep Vein Thrombosis (DVT) is expected to dominate the market
By application, deep-vein thrombosis is expected to witness significant growth. A deep-vein thrombosis (DVT) is defined as a blood clot that forms within the deep veins that might occur in the veins of the arms and the mesenteric and cerebral veins. As of 2020, according to the Centers for Disease Control and Prevention (CDC), the exact number of people infected with deep vein thrombosis was unknown, although about 900,000 people were expected to be affected each year in the United States. According to the CDC, one-third of about 33% of people with deep vein thrombosis will have a recurrence within ten years. The Centers for Disease Control and Prevention (CDC) also estimated that 60,000-100,000 Americans die of deep vein thrombosis each year while 10 to 30% of people can die within one month of diagnosis.
Thus, the increasing prevalence of deep vein thrombosis is expected to fuel the production of demand for heparin-based products, thereby augmenting the market growth over the forecast period.
